Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies: High-dose Cyclophosphamide Versus Plerixafor

NCT02997813 is registered in ClinicalTrials.gov with Intergroupe Francophone du Myelome as lead sponsor.

NCT NCT02997813
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02997813 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies: High-dose Cyclophosphamide Versus Plerixafor
Lead sponsor
Intergroupe Francophone du Myelome
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
December 31, 2016
Enrollment
112 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

blood stem cell transplant failure, multiple myeloma